Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma

Therapeutic Option ◽

Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma ◽

10.2147/jhc.s278517 ◽

2021 ◽

Vol Volume 8 ◽

pp. 19-21

Author(s):

Qian Liu ◽

Xifeng Dong

Keyword(s):

De Novo ◽

Therapeutic Option ◽

Cholesterol Biosynthesis ◽

De Novo Lipogenesis ◽

Abstract B39: Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma

10.1158/1538-7445.fbcr15-b39 ◽

2016 ◽

Author(s):

Stefanie Hauck ◽

Sabrina Khageh Hosseini ◽

Josephine Wesely ◽

Dieter Steinhilber ◽

Jörg Schulze ◽

...

Keyword(s):

Therapeutic Option ◽

Muscle RAS oncogene homolog is a novel therapeutic target gene contributing to hepatocellular carcinoma progression and sorafenib-resistance

Zeitschrift für Gastroenterologie ◽

10.1055/s-0037-1612826 ◽

2018 ◽

Vol 56 (01) ◽

pp. E2-E89

Author(s):

M Bildstein ◽

C Hellerbrand ◽

A Bosserhoff ◽

P Dietrich

Keyword(s):

Therapeutic Target ◽

Target Gene ◽

Ras Oncogene ◽

A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer

International Immunopharmacology ◽

10.1016/j.intimp.2021.107790 ◽

2021 ◽

Vol 96 ◽

pp. 107790

Author(s):

Bao-Kang Wu ◽

Qian-Hui Chen ◽

Dan Pan ◽

Bing Chang ◽

Li-Xuan Sang

Keyword(s):

Therapeutic Strategy ◽

Anti Cancer ◽

Copper-impregnated socks: A novel therapeutic option for combating occupational dermatophytosis

Medical Journal Armed Forces India ◽

10.1016/j.mjafi.2021.01.010 ◽

2021 ◽

Author(s):

Sukriti Baveja ◽

Chetan C. Patil ◽

Surbhi Vashisht ◽

Deepak Vashisht ◽

Vikas Pathania ◽

...

Keyword(s):

Therapeutic Option ◽

The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea

Dermatology and Therapy ◽

10.1007/s13555-015-0078-1 ◽

2015 ◽

Vol 5 (3) ◽

pp. 171-181 ◽

Cited By ~ 10

Author(s):

Andrew William Johnson ◽

Sandra Marchese Johnson

Keyword(s):

Therapeutic Option ◽

Facial Erythema ◽

Brimonidine Tartrate ◽

Restoration of early deficiency of axonal guidance signaling by guanxinning injection as a novel therapeutic option for acute ischemic stroke

Pharmacological Research ◽

10.1016/j.phrs.2021.105460 ◽

2021 ◽

pp. 105460

Author(s):

Guangxu Xiao ◽

Ming Lyu ◽

Zhixiong Li ◽

Linghua Cao ◽

Xinyan Liu ◽

...

Keyword(s):

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Therapeutic Option ◽

Axonal Guidance ◽

4: DHMEQ a novel therapeutic option for the treatment of inflammatory mediated cisplatin resistant non-small cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(15)50004-4 ◽

2015 ◽

Vol 87 ◽

pp. S2

Author(s):

A.-M. Baird ◽

P. Godwin ◽

S. Heavey ◽

M. Barr ◽

K. Umezawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Therapeutic Option ◽

Small Cell ◽

Small Cell Lung ◽

A novel therapeutic strategy for hepatocellular carcinoma: immunomodulation by Flt3-Ligand (Flt3L) following whole liver irradiation and radio-inducible HSV-TK gene therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(01)02018-1 ◽

2001 ◽

Vol 51 (3) ◽

pp. 105-106

Author(s):

Y. Kawashita ◽

N.J. Deb ◽

M.K. Garg ◽

Z. Fan ◽

A.A. Alfieri ◽

...

Keyword(s):

Gene Therapy ◽

Therapeutic Strategy ◽

Flt3 Ligand ◽

Erythropoietin — A Novel Therapeutic Option for Cachectic Patients

Pharmacotherapy of Cachexia ◽

10.1201/9780849333798.ch23 ◽

2005 ◽

pp. 407-424

Author(s):

Ewa Jankowska ◽

Piotr Ponikowski ◽

Waldemar Banasiak

Keyword(s):

Therapeutic Option ◽